| Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation W Besse, S Mansour, K Jatwani, CC Nast, UC Brewster BMC nephrology 17, 1-8, 2016 | 37 | 2016 |
| Nivolumab-induced psoriatic arthritis in a patient with advanced small cell lung cancer K Jatwani, H Kaur, K Chugh, S Jatwani JCR: Journal of Clinical Rheumatology 27 (5), e162-e163, 2021 | 10 | 2021 |
| Tumid lupus erythematosus and systemic lupus erythematosus: a report on their rare coexistence K Jatwani, K Chugh, OS Osholowu, S Jatwani Cureus 12 (4), 2020 | 10 | 2020 |
| Bronchiolitis obliterans organising pneumonia as an initial manifestation in a patient with systemic lupus erythematosus: a rare presentation S Jatwani, R Handa, K Jatwani, K Chugh Case Reports 2018, bcr-2017-224094, 2018 | 6 | 2018 |
| Trends in hospitalisations and inpatient mortality from acute myocardial infarction among patients with psoriatic arthritis: An analysis of nationwide inpatient sample 2004–2014 S Jatwani, K Jatwani, P Tiwari, N Wadhwa, K Chugh Clin. Exp. Rheumatol 39, 790-794, 2021 | 4 | 2021 |
| Hairy cell leukemia masquerading as CD5+ lymphoproliferative disease: the importance of BRAF V600E testing in diagnosis and treatment D Soong, P Kumar, K Jatwani, J Park, A Dogan, J Taylor JCO precision oncology 5, 2021 | 3 | 2021 |
| Etiologies and predictors of 30-day readmission in patients undergoing induction chemotherapy for acute myeloid leukemia S Handa, K Gupta, JS Sidhu, G Petrone, S Rajeeve, K Jatwani Blood 134, 4759, 2019 | 3 | 2019 |
| Impact of hospital teaching status on hospital costs and length of stay for heart failure patients with history of hematopoietic stem cell transplant: a national inpatient … K Jatwani, S Jatwani, K Chugh Biology of Blood and Marrow Transplantation 25 (3), S377, 2019 | 2 | 2019 |
| Bispecific antibodies in lung cancer: a state-of-the-art review AA Khosla, K Jatwani, R Singh, A Reddy, I Jaiyesimi, A Desai Pharmaceuticals 16 (10), 1461, 2023 | 1 | 2023 |
| Racial disparity in the clinical outcomes of HER2-low and HER2-zero early-stage breast cancer. S Gandhi, K Catalfamo, K Attwood, A Kapoor, K Jatwani, AM Roy Journal of Clinical Oncology 41 (16_suppl), e12602-e12602, 2023 | 1 | 2023 |
| Impact of neoadjuvant chemotherapy on pathological stage and survival in sarcomatoid bladder cancer. AM Roy, K Jatwani, V Muthusamy Kumarasamy, S Perimbeti, C Jiang, ... Journal of Clinical Oncology 41 (6_suppl), 530-530, 2023 | 1 | 2023 |
| Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non–Small-Cell Lung Cancer: Case Series A Gupta, K Jatwani, K Gupta, J Qiu, GK Dy JCO Precision Oncology 7, e2200476, 2023 | 1 | 2023 |
| Survival outcomes with radical cystectomy (RC) in localized clinically node-positive bladder cancer (CNBC). S Perimbeti, C Jiang, L Deng, K Jatwani, A Kaur, S George, GS Chatta, ... Journal of Clinical Oncology 40 (6_suppl), 520-520, 2022 | 1 | 2022 |
| Palliative Care Consultation Reduces 30-Day Readmission Rates for Hospitalized Patients with End-Stage Chronic Obstructive Pulmonary Disease (FR440C) J Sheehan, KS Ho, S Alipour, K Jatwani, P Kohli, J Fung Journal of Pain and Symptom Management 59 (2), 468, 2020 | 1 | 2020 |
| A case of long-term survival of 36 months in the setting of extensive-disease small-cell lung cancer G Ramineni, BS Bindra, K Jatwani, D Singh, R Khillan Cureus 11 (9), 2019 | 1 | 2019 |
| A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC). SA Funt, K Jatwani, M Makris, AM Regazzi, CH Lee, MY Teo, DJ McHugh, ... Journal of Clinical Oncology 37 (15_suppl), 4559-4559, 2019 | 1 | 2019 |
| Opportunistic infections, is non Hodgkin Lymphoma one of the risk factors for mortality? K Jatwani, S Jatwani, S Rajeeve, K Chugh, RK Sharma, S Perimbeti, ... Blood 132, 5818, 2018 | 1 | 2018 |
| BIO24-029: Predicting Disparities in Adverse Dispositions Following Major Surgery for Lung Cancer Using Machine Learning AA Khosla, V Rajan, MA Ganiyani, N Batra, K Jatwani, R Singh, Y Zhang, ... Journal of the National Comprehensive Cancer Network: JNCCN 22 (2.5), BIO24-029, 2024 | | 2024 |
| Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma H Li, S Shyam Sunder, K Jatwani, Y Bae, L Deng, Q Liu, GK Dy, ... Cancers 16 (4), 744, 2024 | | 2024 |
| A randomized phase II trial of neoadjuvant chemokine modulation in patients with localized prostate cancer undergoing radical prostatectomy. K Jatwani, S Kalathil, R Slomba, B Farmer, K Attwood, AM Roy, P Singh, ... Journal of Clinical Oncology 42 (4_suppl), 340-340, 2024 | | 2024 |
